Gilead Sciences | GILD - Pre Tax Profit

Gilead Sciences reported $2.52B in Pre-Tax Profit for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Pre Tax Profit Change
Abbvie ABBV:US USD 7.41B 84M
Agios Pharmaceuticals AGIO:US USD 36.53M 118.27M
ALKERMES ALKS:US USD 25.82M 25.69M
Alnylam Pharmaceuticals ALNY:US USD -207021000 122.34M
Amgen AMGN:US USD 2.54B 364M
Biomarin Pharmaceutical BMRN:US USD -17558000 15.65M
Bluebird Bio BLUE:US USD -76513000 16.99M
Coherus Biosciences CHRS:US USD -58870000 27.78M
Eli Lilly And LLY:US USD 2.04B 38.3M
Gilead Sciences GILD:US USD 2.52B 357M
GlaxoSmithKline GSK:LN GBP 1.36B 1.07B
Glaxosmithkline GSK:US GBP 1.6B 409.03M
Intercept Pharmaceuticals ICPT:US USD -17543000 86.54M
Johnson & Johnson JNJ:US USD 7.42B 655M
Merk MRK:US USD 4.89B 560M
Moderna Inc MRNA:US USD 1.66B 438M
Neurocrine Biosciences NBIX:US USD 117.9M 20M
Novartis NOVN:VX USD 3.86B 195M
Pfizer PFE:US USD 7.38B 3.3B
Ptc Therapeutics PTCT:US USD -156309000 29.1M
Puma Biotechnology PBYI:US USD -5300000 5.01M
Regeneron Pharmaceuticals REGN:US USD 1.63B 188.9M
Sangamo Biosciences SGMO:US USD -51714000 1.41M
Sanofi SAN:FP EUR 2.75B 1.68B
Sarepta Therapeutics SRPT:US USD -101306000 155.11M
United Therapeutics UTHR:US USD 178.8M 133.7M
Vertex Pharmaceuticals VRTX:US USD 1.2B 122.8M
YTE INCY:US USD 178.62M 401K